The FDA has also confirmed that shortages of Novos Wegovy and Ozempic have been resolved, removing the drugs from the shortage list, Reuters reported Friday
The order includes a Most Favored Nation (MFN) exemption: companies that agree to match the lowest price they charge in any other developed country, and commit to onshoring manufacturing, pay zero tariff through January 2029
As a result, patients who utilize GLP-1 treatments typically experience reduced calorie intake and gradual, sustainable weight loss
Before stopping the medications, people treated for obesity lost about 8.4% of their body weight, while those treated for type 2 diabetes lost about 4.4% on average
Dividing the daily dose into smaller doses improves absorption
The drugs have proven to be remarkable cash cows for their manufacturers